Micromet, Inc. (NASDAQ:MITI)

idvst8 (< 20) Submitted: 7/22/2011 2:07:53 PM : Start Price: $6.12 MITI Score: +56.65

MITI - Offer huge upside in the BioTech sector. I firmly believe this company will get bought out in the next 12-24 months.

TROYHEOF (< 20) Submitted: 7/7/2011 11:35:39 AM : Start Price: $5.98 MITI Score: +61.29

I like the research MITI is doing

shanelopez (< 20) Submitted: 6/30/2011 9:51:54 PM : Start Price: $5.77 MITI Score: +65.21

Market sentiment on selected stocks

clancykid (< 20) Submitted: 12/4/2010 11:09:20 AM : Start Price: $7.73 MITI Score: -7.26

From the board chair to the other principals, they are all selling shares like there is no tomorrow. Get out now while the gettin is good!

kblumbio (< 20) Submitted: 6/30/2010 1:02:17 PM : Start Price: $6.47 MITI Score: +11.43

Phase 1 Data on MT110 2nd Bite for solid tumors late this year early next!

Stageplayer (< 20) Submitted: 6/3/2010 11:24:06 AM : Start Price: $6.50 MITI Score: +19.27

This company may be on the verge of a possible cure for cancer.

gdleon (< 20) Submitted: 7/14/2009 12:29:50 AM : Start Price: $4.97 MITI Score: +37.19

their patented safe antibody platform will change the standard in treatment of cancer. they are going to create a royality system of revenues sold throughout the pharma industry. in 10 years , heres another 10 bagger.
Dr. D

noescaper (23.00) Submitted: 6/1/2009 9:17:23 PM : Start Price: $4.31 MITI Score: -77.89

4.5 and above is strong resistance in the near term.

minimidgy (98.71) Submitted: 4/23/2009 11:51:13 AM : Start Price: $3.56 MITI Score: -109.15

- Forecasted Earnings per Share of $-0.73 per share
- P/E of of -4.82
- Earnings Yield of -20.74 percent
- Growth to P/E Ratio of -0.20

LawfordCap (99.92) Submitted: 3/24/2009 10:18:25 AM : Start Price: $2.75 MITI Score: -193.92

bad company ready to go down

R3ALGOOD (< 20) Submitted: 10/13/2008 7:29:22 PM : Start Price: $4.69 MITI Score: +72.21

Listen carefully: This stock will be at $20 on or around December 6th-9th. These dates are the 50th ASH meeting where MITI will present phae II data from its drug MT203. If results are positive, the stock will soar. So far, results have been close to 100% positive. December will be the time of the catalyst. Get in before its too late. Good Luck

TheParadox (83.82) Submitted: 9/24/2008 2:26:20 AM : Start Price: $4.92 MITI Score: -80.91

The worst company on earth.

WOODYHAZE (< 20) Submitted: 8/28/2008 9:23:09 AM : Start Price: $6.20 MITI Score: +45.20

Hope I'm not too late on this one....

deylux (< 20) Submitted: 8/26/2008 4:45:11 PM : Start Price: $6.26 MITI Score: -41.72

Riding down

postbusters (86.25) Submitted: 8/20/2008 8:47:11 AM : Start Price: $5.87 MITI Score: +53.21

I've been in MITI since Dec 07. Potential of BITE is amazing and although MT103 is their lead candidate, they have many BITE platforms in development.

Check out the Science Magazine article that just rocketed the stock into the high 5's (as high as 6.50. Listen to the company CC that was predicated on the Science Magazine article. Check out the Science Advisory Board panel mambers that MITI stood up a a steering committee for their pending products.

7 of 7 patients tested at the highest doses (which are 5 orders of magnitude lower than existing antibody therapies) showed complete or partial remission. Longest treated candidate is still in remission over a year later.

Even though the stock has moved significantly this year, if the additional data which will be released in Dec at ASCO continues to show promise, the stock will continue to move up sharply.

rotordad80 (83.44) Submitted: 8/19/2008 1:02:49 AM : Start Price: $5.95 MITI Score: +50.72

cancer research should provide valuable results and may end some forms of cancer